Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-13

Clinical Trial Update: Vitamin D Replacement in Nonalcoholic Fatty Liver Disease

View source ↗

Summary

A completed clinical trial evaluating Vitamin D3 (cholecalciferol) replacement in patients with Nonalcoholic Fatty Liver Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Nonalcoholic Fatty Liver | Status: COMPLETED